The Safety and Serious Adverse Events of Approved ALK Inhibitors in Malignancies: A Meta-Analysis

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s190098
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

P012 Pooled Safety Analysis for Two Generations ALK Inhibitors: A Meta Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Systematic Review and Meta-Analysis of Selected Toxicities of Approved ALK Inhibitors in Metastatic Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

Therapeutic Effects and Associated Adverse Events of Multikinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Serious Adverse Events After Cataract Surgery

Current Opinion in Ophthalmology
MedicineOphthalmology
2012English

Efficacy and Safety of Vorapaxar for the Prevention of Adverse Cardiac Events in Patients With Coronary Artery Disease: A Meta-Analysis

Cardiovascular Diagnosis and Therapy
Cardiovascular MedicineCardiology
2016English

Serious Adverse Events in Academic Critical Care Research

CMAJ
Medicine
2008English

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

The Prevalence of Medication-Related Adverse Events in Inpatients—a Systematic Review and Meta-Analysis

European Journal of Clinical Pharmacology
MedicinePharmacology
2017English

Surveillance of Serious Adverse Events Following Immunization in Resource Poor Settings

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy